Search:

seizure, Epilepsy, Schizencephaly, Porencephaly, Stroke Blakely Hiner seizure, Epilepsy, Schizencephaly, Porencephaly, Stroke Blakely Hiner

2024: Multiorgan manifestations of COL4A1 and COL4A2 variants and proposal for a clinical management protocol

COL4A1/2 variants are associated with highly variable multiorgan manifestations. Depicting the whole clinical spectrum of COL4A1/2-related manifestations is challenging, and there is no consensus on management and preventative strategies.

Read More
Stroke Blakely Hiner Stroke Blakely Hiner

2022: Systematic Review of Cerebral Phenotypes Associated With Monogenic Cerebral Small-Vessel Disease

Background Cerebral small-vessel disease (cSVD) is an important cause of stroke and vascular dementia. Most cases are multifactorial, but an emerging minority have a monogenic cause. While NOTCH3 is the best-known gene, several others have been reported. We aimed to summarize the cerebral phenotypes associated with these more recent cSVD genes.

Read More
Stroke Blakely Hiner Stroke Blakely Hiner

2021: Hereditary Cerebral Small Vessel Diseases and Stroke: A Guide for Diagnosis and Management

Background Cerebral small-vessel disease (cSVD) is an important cause of stroke and vascular dementia. Most cases are multifactorial, but an emerging minority have a monogenic cause. While NOTCH3 is the best-known gene, several others have been reported. We aimed to summarize the cerebral phenotypes associated with these more recent cSVD genes.

Read More
Patient Registry Blakely Hiner Patient Registry Blakely Hiner

Gould syndrome patient registry article

Recently, patient advocacy groups started using the name Gould syndrome to describe clinical features ofCOL4A1 and COL4A2 mutations. Gould syndrome is increasingly identified in genetic screening panels,and because it is a rare disease, there is a disproportionate burden on families to understand the diseaseand chart the course for clinical care. Among the chief concerns for […]

Read More
Blakely Hiner Blakely Hiner

Research Paper: 2019 Jones

4-Sodium phenyl butyric acid has both efficacy and counter-indicative effects in the treatment of Col4a1 disease

Read More